To determine if treatment of disseminated candidiasis with caspofungin (CF) could artificially increase β-glucan exposure, we used different levels of CF to identify a sub-therapeutic dose (30 μg/kg) that would allow isolation of live fungi that had grown in the presence of drug (Figure 4A). This evidence concerns the gene PPIB and disseminated candidiasis.